New patent for Endo Pharms drug OPANA ER

Annual Drug Patent Expirations for OPANA+ER Opana Er is a drug marketed by Endo Pharms and is included in two NDAs. There are ten patents protecting this drug and six…
The post New patent for Endo Pharms drug OPANA ER appeared first on DrugPatentWatch …


Drug Patent Expirations for the Week of March 21, 2021

XOPENEX (levalbuterol hydrochloride) Akorn Patent: 6,451,289 Expiration: Mar 21, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post D…


Biotechblog